Use of the In Situ Right Internal Thoracic Artery as an Alternative Single-Inflow Source

Taeyoung Yun1, Ji Seong Kim1, Yoonjin Kang1

  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Insights

The in situ right internal thoracic artery (RITA) serves as an effective alternative to the left internal thoracic artery (LITA) in coronary artery bypass grafting (CABG). Long-term outcomes and graft patency are comparable between RITA and LITA composite grafting.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Vascular Grafting

Background:

  • Coronary artery bypass grafting (CABG) is a critical procedure for treating coronary artery disease.
  • The internal thoracic artery (ITA) is a preferred graft conduit due to its long-term patency.
  • Evaluating alternative ITA sources is essential for optimizing CABG outcomes.

Purpose of the Study:

  • To assess the efficacy of the in situ right internal thoracic artery (RITA) as a single-inflow source in CABG.
  • To compare RITA composite grafting with the conventional left internal thoracic artery (LITA) composite grafting.
  • To determine long-term graft patency and clinical outcomes for RITA-based CABG.

Main Methods:

  • A retrospective study comparing 73 patients undergoing CABG with RITA composite grafting (RITA group) versus LITA composite grafting (LITA group).
  • 1:1 propensity score matching was employed to create comparable patient cohorts.
  • Angiographic patency and clinical outcomes, including reintervention and major adverse cardiac events, were evaluated.

Main Results:

  • No significant difference in overall graft patency rates at 1 year (92.2% vs. 92.5%) and 5 years (87.3% vs. 90.4%) between the RITA and LITA groups.
  • Cumulative incidences of reintervention and major adverse cardiac events were similar between the two groups.
  • Propensity score matching yielded 43 comparable pairs for analysis.

Conclusions:

  • The in situ RITA is a viable and effective alternative to the LITA for single-inflow composite grafting in CABG.
  • RITA-based composite grafting demonstrates comparable long-term graft patency and clinical outcomes to LITA-based grafting.
  • This finding supports the expanded use of RITA in CABG procedures.
Abstract